{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:56:50Z","timestamp":1790881010669,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jid.2016.07.016","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T02:44:12Z","timestamp":1475808252000},"page":"2444-2452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["High GDF-15 Serum Levels Independently Correlate with Poorer Overall Survival of Patients with Tumor-Free Stage III and Unresectable Stage IV Melanoma"],"prefix":"10.1016","volume":"136","author":[{"given":"Benjamin","family":"Weide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Kuzkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Uder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick N.","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Mittelbronn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Wischhusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.07.016_bib1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1124\/mol.59.4.901","article-title":"Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities","volume":"59","author":"Baek","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jid.2016.07.016_bib2","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1053\/j.gastro.2006.09.015","article-title":"Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia","volume":"131","author":"Baek","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jid.2016.07.016_bib3","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2016.07.016_bib4","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2016.07.016_bib5","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-05-4067","article-title":"Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer","volume":"66","author":"Bauskin","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2016.07.016_bib6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2217\/fon.13.263","article-title":"Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer","volume":"10","author":"Blanco-Calvo","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.jid.2016.07.016_bib7","first-page":"1448","article-title":"Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions","volume":"20","author":"Bock","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jid.2016.07.016_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/jid.2008.270","article-title":"Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity","volume":"129","author":"Boyle","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.07.016_bib9","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-08-3126","article-title":"Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer","volume":"15","author":"Brown","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2016.07.016_bib10","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2016.07.016_bib11","first-page":"649","article-title":"NSAID activated gene (NAG-1), a modulator of tumorigenesis","volume":"39","author":"Eling","year":"2006","journal-title":"J\u00a0Biochem Mol Biol"},{"key":"10.1016\/j.jid.2016.07.016_bib14","doi-asserted-by":"crossref","first-page":"e43833","DOI":"10.1371\/journal.pone.0043833","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice","volume":"7","author":"Husaini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2016.07.016_bib15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1","volume":"13","author":"Johnen","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2016.07.016_bib16","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/cdd.2015.9","article-title":"Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death","volume":"22","author":"Jones","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jid.2016.07.016_bib17","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1158\/1078-0432.CCR-10-2402","article-title":"Plasma markers for identifying patients with metastatic melanoma","volume":"17","author":"Kluger","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2016.07.016_bib18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.22126","article-title":"The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003","volume":"107","author":"Lasithiotakis","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jid.2016.07.016_bib19","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.18632\/oncotarget.6017","article-title":"Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma","volume":"7","author":"Ma","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2016.07.016_bib21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1124\/jpet.105.100081","article-title":"Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene\/macrophage inhibitory cytokine-1\/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth","volume":"318","author":"Martinez","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jid.2016.07.016_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1600-0625.2011.01254.x","article-title":"Identification of new genes associated with melanoma","volume":"20","author":"Mauerer","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2016.07.016_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.22196","article-title":"Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer","volume":"224","author":"Mimeault","year":"2010","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jid.2016.07.016_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/bjc.2012.484","article-title":"Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1","volume":"108","author":"Mimeault","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2016.07.016_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/onc.2015.95","article-title":"NAG-1\/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway","volume":"35","author":"Min","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2016.07.016_bib26","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/ijc.23794","article-title":"The prognostic value of serum S100B in patients with cutaneous melanoma: a meta-analysis","volume":"123","author":"Mocellin","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2016.07.016_bib27","first-page":"563","article-title":"S3-guideline \u201cdiagnosis, therapy and follow-up of melanoma\u201d\u2014short version","volume":"11","author":"Pflugfelder","year":"2013","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2016.07.016_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/1055-9965.EPI-06-0841","article-title":"Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases","volume":"16","author":"Selander","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jid.2016.07.016_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ygyno.2010.05.032","article-title":"Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer","volume":"118","author":"Staff","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jid.2016.07.016_bib33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00417-011-1786-6","article-title":"GDF-15: a novel serum marker for metastases in uveal melanoma patients","volume":"250","author":"Suesskind","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jid.2016.07.016_bib35","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/bjc.2011.112","article-title":"Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer","volume":"104","author":"Wallin","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2016.07.016_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bcp.2012.11.025","article-title":"The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1\/GDF15) in cancer","volume":"85","author":"Wang","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jid.2016.07.016_bib37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/bjc.2012.306","article-title":"Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis","volume":"107","author":"Weide","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2016.07.016_bib38","doi-asserted-by":"crossref","first-page":"e81624","DOI":"10.1371\/journal.pone.0081624","article-title":"Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy","volume":"8","author":"Weide","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2016.07.016_bib39","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1245\/s10434-013-2949-y","article-title":"S-100B: a stronger prognostic biomarker than LDH in stage IIIB-C melanoma","volume":"20","author":"Wevers","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jid.2016.07.016_bib40","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.oraloncology.2008.07.017","article-title":"Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in\u00a0vitro cell proliferation in oral squamous cell carcinoma","volume":"45","author":"Zhang","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jid.2016.07.016_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00432-009-0691-4","article-title":"Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin\/+ mouse model of intestinal cancer","volume":"136","author":"Zimmers","year":"2010","journal-title":"J\u00a0Cancer Res Clin Oncol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1632125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1632125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:17:47Z","timestamp":1601111867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1632125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0022202X1632125X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.07.016","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High GDF-15 Serum Levels Independently Correlate with Poorer Overall Survival of Patients with Tumor-Free Stage III and Unresectable Stage IV Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}